Clinical trial
Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease
NCT00286156 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease
- Lead sponsor
- The Cleveland Clinic
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- October 31, 2006
- Completion date
- December 31, 2014
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.